Zylox-Tonbridge Medical Technology HK$2.56 billion IPO
We advised Zylox-Tonbridge Medical Technology on its IPO and HKEX listing
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Nayuki Holdings HK$5.1 billion IPO
We advised Nayuki Holdings on its IPO and HKEX listing
Youran Dairy HK$5 billion IPO
We advised Youran Dairy on its IPO and HKEX listing
CARsgen Therapeutics HK$3.1 billion IPO
We advised CARsgen Therapeutics on its IPO and HKEX listing
Linklogis HK$8 billion IPO
We advised Linklogis on its IPO and HKEX listing
Bairong HK$3.76 billion IPO
We advised the underwriters on the IPO and HKEX listing
Baidu HK$23.9 billion IPO and secondary listing on the Hong Kong Stock Exchange
In addition to the HKEX listing, Baidu’s ADSs trade on the Nasdaq Global Select Market
JOINN Laboratories HK$6.5 billion IPO
We advised JOINN Laboratories on its IPO and HKEX listing.
Pop Mart HK$5.2 billion IPO and Hong Kong listing
Davis Polk advised Pop Mart International Group Limited in connection with its initial public offering and listing on the Hong Kong Stock Exchange and an international offering in reliance…
Tigermed HK$10.7 billion IPO and Hong Kong listing
Davis Polk advised Hangzhou Tigermed Consulting Co., Ltd. in connection with its initial public offering and listing on the Hong Kong Stock Exchange and an international offering in…